Financial Statements of Parent Company Guarantor - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 26, 2015	Jun. 27, 2015	Mar. 28, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Revenue, Net	$ 1,188.1	$ 1,210.7	$ 1,301.2	$ 1,190.0	$ 1,289.0	$ 1,112.8	$ 1,167.1	$ 1,047.5	$ 4,890.0	$ 4,616.4	$ 4,666.8
Operating activities
Net cash provided by (used for) operating activities									861.4	739.3	1,008.4
Investing activities
Capital expenditures									(117.8)	(91.3)	(83.7)
Proceeds from sale of property and equipment									24.7	4.6	1.9
Acquisitions, net of cash acquired	(25.0)				(0.9)		(96.0)		(25.0)	(1,913.9)	(12.3)
Intercompany Loan Activity, Net									0.0		0.0
Other									(5.2)	(3.0)	0.2
Net Cash Provided by (Used in) Investing Activities, Continuing Operations									(123.3)	(2,003.6)	(93.9)
Cash Provided by (Used in) Investing Activities, Discontinued Operations									1.5	38.1	(34.4)
Net Cash Provided by (Used in) Investing Activities									(121.8)	(1,965.5)	(128.3)
Financing activities
Net receipts (repayments) of short-term borrowings									0.8	(2.3)	0.5
Net receipts (repayments) of commercial paper and revolving long-term debt									(385.3)	363.5	468.6
Proceeds from long-term debt									0.0	1,714.8	2.2
Repayment of long-term debt									(0.7)	(356.6)	(16.8)
Debt issuance costs									0.0	(26.8)	(3.1)
Net change in advances to subsidiaries									0.0	0.0	0.0
Excess tax benefits from share-based compensation									8.0	6.0	12.6
Shares issued to employees, net of shares withheld									20.7	19.4	37.0
Repurchases of ordinary shares									0.0	(200.0)	(1,150.0)
Dividends paid									(243.6)	(231.7)	(211.4)
Distributions to noncontrolling interest									0.0	0.0	(134.7)
Net cash provided by (used for) financing activities									(600.1)	1,286.3	(995.1)
Effect of exchange rate changes on cash and cash equivalents									(27.3)	(44.2)	(30.6)
Change in cash and cash equivalents									112.2	15.9	(145.6)
Cash and cash equivalents, beginning of year				126.3				110.4	126.3	110.4	256.0
Cash and cash equivalents, end of year	238.5				126.3				238.5	126.3	110.4
Cost of goods sold									3,095.9	3,017.6	3,046.3
Gross profit	440.1	440.9	481.8	431.3	432.5	394.7	415.3	356.3	1,794.1	1,598.8	1,620.5
Selling, General and Administrative Expense									979.3	884.0	985.6
Research and Development Expense									114.1	98.7	96.4
Impairment of goodwill and trade names									13.3	0.0	0.0
Operating Income (Loss)	161.8	$ 182.8	$ 203.4	152.7	171.7	$ 152.9	$ 170.8	120.7	700.7	616.1	538.5
Parent Company Guarantor
Condensed Financial Statements, Captions [Line Items]
Revenue, Net									0.0	0.0	0.0
Operating activities
Net cash provided by (used for) operating activities									522.7	(43.0)	169.0
Investing activities
Capital expenditures									0.0	0.0	0.0
Proceeds from sale of property and equipment									0.0	0.0	0.0
Acquisitions, net of cash acquired									0.0	0.0	0.0
Intercompany Loan Activity, Net									0.0	0.0	0.0
Other									0.0	0.0	0.0
Net Cash Provided by (Used in) Investing Activities, Continuing Operations									0.0
Net Cash Provided by (Used in) Investing Activities									0.0	0.0	0.0
Financing activities
Net receipts (repayments) of short-term borrowings									0.0	0.0	0.0
Net receipts (repayments) of commercial paper and revolving long-term debt									0.0	0.0	0.0
Proceeds from long-term debt										0.0	0.0
Repayment of long-term debt									0.0	0.0	0.0
Debt issuance costs										0.0	0.0
Net change in advances to subsidiaries									(299.8)	471.7	741.1
Excess tax benefits from share-based compensation									0.0	0.0	0.0
Shares issued to employees, net of shares withheld									20.7	3.0	0.0
Repurchases of ordinary shares										(200.0)	(699.2)
Dividends paid									(243.6)	(231.7)	(211.4)
Distributions to noncontrolling interest											0.0
Net cash provided by (used for) financing activities									(522.7)	43.0	(169.5)
Effect of exchange rate changes on cash and cash equivalents									0.0	0.0	0.0
Change in cash and cash equivalents									0.0	0.0	(0.5)
Cash and cash equivalents, beginning of year				0.0				0.0	0.0	0.0	0.5
Cash and cash equivalents, end of year	0.0				0.0				0.0	0.0	0.0
Cost of goods sold									0.0	0.0	0.0
Gross profit									0.0	0.0	0.0
Selling, General and Administrative Expense									15.8	33.7	25.3
Research and Development Expense									0.0	0.0	0.0
Operating Income (Loss)									(15.8)	(33.7)	(25.3)
Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue, Net									0.0	0.0	0.0
Operating activities
Net cash provided by (used for) operating activities									463.1	(48.7)	208.6
Investing activities
Capital expenditures									0.0	0.0	0.0
Proceeds from sale of property and equipment									0.0	0.0	0.0
Acquisitions, net of cash acquired									0.0	0.0	0.0
Intercompany Loan Activity, Net									0.0	0.0	0.0
Other									0.0	0.0	0.0
Net Cash Provided by (Used in) Investing Activities, Continuing Operations									0.0
Net Cash Provided by (Used in) Investing Activities									0.0	0.0	0.0
Financing activities
Net receipts (repayments) of short-term borrowings									0.0	0.0	0.0
Net receipts (repayments) of commercial paper and revolving long-term debt									0.0	0.0	0.0
Proceeds from long-term debt										0.0	0.0
Repayment of long-term debt									0.0	0.0	0.0
Debt issuance costs										0.0	0.0
Net change in advances to subsidiaries									(463.1)	48.7	(208.6)
Excess tax benefits from share-based compensation									0.0	0.0	0.0
Shares issued to employees, net of shares withheld									0.0	0.0	0.0
Repurchases of ordinary shares										0.0	0.0
Dividends paid									0.0	0.0	0.0
Distributions to noncontrolling interest											0.0
Net cash provided by (used for) financing activities									(463.1)	48.7	(208.6)
Effect of exchange rate changes on cash and cash equivalents									0.0	0.0	0.0
Change in cash and cash equivalents									0.0	0.0	0.0
Cash and cash equivalents, beginning of year				0.0				0.0	0.0	0.0	0.0
Cash and cash equivalents, end of year	0.0				0.0				0.0	0.0	0.0
Cost of goods sold									0.0	0.0	0.0
Gross profit									0.0	0.0	0.0
Selling, General and Administrative Expense									0.0	2.2	2.6
Research and Development Expense									0.0	0.0	0.0
Operating Income (Loss)									0.0	(2.2)	(2.6)
Subsidiary Issuer
Condensed Financial Statements, Captions [Line Items]
Revenue, Net									0.0	0.0	0.0
Operating activities
Net cash provided by (used for) operating activities									469.5	(5.8)	207.0
Investing activities
Capital expenditures									0.0	0.0	0.0
Proceeds from sale of property and equipment									0.0	0.0	0.0
Acquisitions, net of cash acquired									0.0	0.0	0.0
Intercompany Loan Activity, Net									667.3	891.0	37.8
Other									0.0	0.0	0.0
Net Cash Provided by (Used in) Investing Activities, Continuing Operations									667.3	891.0	37.8
Net Cash Provided by (Used in) Investing Activities									667.3	891.0	37.8
Financing activities
Net receipts (repayments) of short-term borrowings									0.0	0.0	0.0
Net receipts (repayments) of commercial paper and revolving long-term debt									(385.8)	346.9	458.7
Proceeds from long-term debt										1,714.8	0.0
Repayment of long-term debt									0.0	(350.0)	0.0
Debt issuance costs										(26.8)	(3.1)
Net change in advances to subsidiaries									(778.9)	(2,553.7)	(747.3)
Excess tax benefits from share-based compensation									0.0	0.0	0.0
Shares issued to employees, net of shares withheld									0.0	0.0	0.0
Repurchases of ordinary shares										0.0	0.0
Dividends paid									0.0	0.0	0.0
Distributions to noncontrolling interest											0.0
Net cash provided by (used for) financing activities									(1,164.7)	(868.8)	(291.7)
Effect of exchange rate changes on cash and cash equivalents									27.8	(16.4)	0.0
Change in cash and cash equivalents									(0.1)	0.0	(46.9)
Cash and cash equivalents, beginning of year				0.1				0.1	0.1	0.1	47.0
Cash and cash equivalents, end of year	0.0				0.1				0.0	0.1	0.1
Cost of goods sold									0.0	0.0	0.0
Gross profit									0.0	0.0	0.0
Selling, General and Administrative Expense									1.2	5.3	7.7
Research and Development Expense									0.0	0.0	0.0
Operating Income (Loss)									(1.2)	(5.3)	(7.7)
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenue, Net									4,890.0	4,616.4	4,666.8
Operating activities
Net cash provided by (used for) operating activities									916.2	767.1	1,093.8
Investing activities
Capital expenditures									(117.8)	(91.3)	(83.7)
Proceeds from sale of property and equipment									24.7	4.6	1.9
Acquisitions, net of cash acquired									(25.0)	(1,913.9)	(12.3)
Intercompany Loan Activity, Net									(191.0)	(295.0)	112.2
Other									(5.2)	(3.0)	0.2
Net Cash Provided by (Used in) Investing Activities, Continuing Operations									(314.3)	2,298.6	18.3
Cash Provided by (Used in) Investing Activities, Discontinued Operations									1.5	38.1	(34.4)
Net Cash Provided by (Used in) Investing Activities									(312.8)	(2,260.5)	(16.1)
Financing activities
Net receipts (repayments) of short-term borrowings									0.8	(2.3)	0.5
Net receipts (repayments) of commercial paper and revolving long-term debt									0.5	16.6	9.9
Proceeds from long-term debt										0.0	2.2
Repayment of long-term debt									(0.7)	(6.6)	(16.8)
Debt issuance costs										0.0	0.0
Net change in advances to subsidiaries									(444.6)	1,507.0	(605.2)
Excess tax benefits from share-based compensation									8.0	6.0	12.6
Shares issued to employees, net of shares withheld									0.0	16.4	37.0
Repurchases of ordinary shares										0.0	(450.8)
Dividends paid									0.0	0.0	0.0
Distributions to noncontrolling interest											(134.7)
Net cash provided by (used for) financing activities									(436.0)	1,537.1	(1,145.3)
Effect of exchange rate changes on cash and cash equivalents									(55.1)	(27.8)	(30.6)
Change in cash and cash equivalents									112.3	15.9	(98.2)
Cash and cash equivalents, beginning of year				126.2				110.3	126.2	110.3	208.5
Cash and cash equivalents, end of year	238.5				126.2				238.5	126.2	110.3
Cost of goods sold									3,095.9	3,017.6	3,046.3
Gross profit									1,794.1	1,598.8	1,620.5
Selling, General and Administrative Expense									962.3	842.8	950.0
Research and Development Expense									114.1	98.7	96.4
Operating Income (Loss)									717.7	657.3	574.1
Eliminations
Condensed Financial Statements, Captions [Line Items]
Revenue, Net									0.0	0.0	0.0
Operating activities
Net cash provided by (used for) operating activities									(1,510.1)	69.7	(670.0)
Investing activities
Capital expenditures									0.0	0.0	0.0
Proceeds from sale of property and equipment									0.0	0.0	0.0
Acquisitions, net of cash acquired									0.0	0.0	0.0
Intercompany Loan Activity, Net									(476.3)	(596.0)	(150.0)
Other									0.0	0.0	0.0
Net Cash Provided by (Used in) Investing Activities, Continuing Operations									(476.3)	(596.0)	(150.0)
Cash Provided by (Used in) Investing Activities, Discontinued Operations									0.0
Net Cash Provided by (Used in) Investing Activities									(476.3)	(596.0)	(150.0)
Financing activities
Net receipts (repayments) of short-term borrowings									0.0	0.0	0.0
Net receipts (repayments) of commercial paper and revolving long-term debt									0.0	0.0	0.0
Proceeds from long-term debt										0.0	0.0
Repayment of long-term debt									0.0	0.0	0.0
Debt issuance costs										0.0	0.0
Net change in advances to subsidiaries									1,986.4	526.3	820.0
Excess tax benefits from share-based compensation									0.0	0.0	0.0
Shares issued to employees, net of shares withheld									0.0	0.0	0.0
Repurchases of ordinary shares										0.0	0.0
Dividends paid									0.0	0.0	0.0
Distributions to noncontrolling interest											0.0
Net cash provided by (used for) financing activities									1,986.4	526.3	820.0
Effect of exchange rate changes on cash and cash equivalents									0.0	0.0	0.0
Change in cash and cash equivalents									0.0	0.0	0.0
Cash and cash equivalents, beginning of year				$ 0.0				$ 0.0	0.0	0.0	0.0
Cash and cash equivalents, end of year	$ 0.0				$ 0.0				0.0	0.0	0.0
Cost of goods sold									0.0	0.0	0.0
Gross profit									0.0	0.0	0.0
Selling, General and Administrative Expense									0.0	0.0	0.0
Research and Development Expense									0.0	0.0	0.0
Operating Income (Loss)									$ 0.0	$ 0.0	$ 0.0